BRPI0818732A2 - Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais. - Google Patents

Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.

Info

Publication number
BRPI0818732A2
BRPI0818732A2 BRPI0818732-0A2A BRPI0818732A BRPI0818732A2 BR PI0818732 A2 BRPI0818732 A2 BR PI0818732A2 BR PI0818732 A BRPI0818732 A BR PI0818732A BR PI0818732 A2 BRPI0818732 A2 BR PI0818732A2
Authority
BR
Brazil
Prior art keywords
epitely
prostaglandine
treating
methods
related conditions
Prior art date
Application number
BRPI0818732-0A2A
Other languages
English (en)
Inventor
Pamela Lipkin
Beverly Lubit
Original Assignee
Pamela Lipkin
Beverly Lubit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pamela Lipkin, Beverly Lubit filed Critical Pamela Lipkin
Publication of BRPI0818732A2 publication Critical patent/BRPI0818732A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0818732-0A2A 2007-10-31 2008-09-23 Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais. BRPI0818732A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98419807P 2007-10-31 2007-10-31
PCT/US2008/077357 WO2009058493A1 (en) 2007-10-31 2008-09-23 Prostaglandin analog compositions and methods to treat epithelial-related conditions

Publications (1)

Publication Number Publication Date
BRPI0818732A2 true BRPI0818732A2 (pt) 2014-10-07

Family

ID=40512720

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818732-0A2A BRPI0818732A2 (pt) 2007-10-31 2008-09-23 Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.

Country Status (12)

Country Link
US (13) US7632868B2 (pt)
EP (1) EP2214482A4 (pt)
JP (1) JP2011502152A (pt)
KR (1) KR20100099145A (pt)
CN (1) CN101969772A (pt)
AU (1) AU2008319145A1 (pt)
BR (1) BRPI0818732A2 (pt)
CA (1) CA2704337A1 (pt)
IL (1) IL205442A0 (pt)
MX (1) MX2010004834A (pt)
RU (1) RU2010121880A (pt)
WO (1) WO2009058493A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
AU2008212820B2 (en) 2007-02-09 2014-01-30 Northwestern University Particles for detecting intracellular targets
US7632868B2 (en) * 2007-10-31 2009-12-15 Meta Cosmetics, Llc Prostaglandin analog compositions to treat epithelial-related conditions
US20100074857A1 (en) * 2008-09-23 2010-03-25 Pamela Lipkin Compositions and methods to treat epithelial-related conditions
AU2009316286B2 (en) 2008-11-24 2016-05-26 Northwestern University Polyvalent RNA-nanoparticle compositions
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
US20100249043A1 (en) * 2009-03-25 2010-09-30 La Canada Ventrures, Inc. Compositions and methods for promoting hair growth
KR20170072367A (ko) 2009-04-15 2017-06-26 노오쓰웨스턴 유니버시티 올리고뉴클레오티드 관능화된 나노입자의 전달
WO2011032159A1 (en) * 2009-09-14 2011-03-17 Meta Comestics, Llc Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
CN102666879B (zh) 2009-10-30 2016-02-24 西北大学 模板化的纳米缀合物
ES2752008T3 (es) * 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
NZ716349A (en) * 2009-11-09 2017-07-28 Allergan Inc Compositions and methods for stimulating hair growth
US20110110879A1 (en) * 2009-11-09 2011-05-12 Avon Products, Inc. Compositions and Methods for Enhancing Eyelashes
US20110112198A1 (en) * 2009-11-09 2011-05-12 Allergan, Inc. Compositions for enhancing hair growth
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
BR112013002584A2 (pt) * 2010-08-02 2016-06-07 Pharma Patent Holding Inc composição, processo de kit para aperfeiçoamento de cabelo
BR112013019519A2 (pt) 2011-01-31 2016-08-09 Allergan Inc método de realce de crescimento capilar
JP5885271B2 (ja) * 2011-02-14 2016-03-15 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ビマトプロストのエステル誘導体の組成物および方法
US20120251613A1 (en) * 2011-03-29 2012-10-04 Agila Specialities Pvt. Ltd. Method for treating vitiligo with a prostaglandin analogue
EP3494959A3 (en) 2011-04-29 2019-09-11 Allergan, Inc. Sustained release latanoprost implant
CN104023749B (zh) 2011-09-14 2019-12-17 西北大学 能穿过血脑屏障的纳米缀合物
JP5873180B2 (ja) * 2011-10-03 2016-03-01 ザ プロクター アンド ギャンブルカンパニー ヘアケア組成物及びその使用方法
US20140093466A1 (en) 2012-10-02 2014-04-03 The Procter & Gamble Company Hair care compositions and methods of use
WO2013052380A2 (en) * 2011-10-05 2013-04-11 Allergan, Inc. Compositions for enhancing nail health
US10059956B2 (en) * 2012-01-17 2018-08-28 Suntory Holdings Limited Glycosyltransferase gene and use thereof
CN103664726A (zh) * 2012-08-31 2014-03-26 南京华狮化工有限公司 氘代比马前列素或其衍生物、它们的制备方法及其应用
EP2968368B1 (en) 2013-03-15 2017-08-09 Glia LLC Cranial delivery of pharmaceuticals
CN105188850A (zh) 2013-05-16 2015-12-23 宝洁公司 毛发增稠组合物及使用方法
WO2016081911A2 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
WO2017021247A1 (en) * 2015-07-31 2017-02-09 Isdin, S.A. Anti-hair loss lotion
FR3060998A1 (fr) * 2016-12-23 2018-06-29 L'oreal Procede de traitement des matieres keratiniques mettant en oeuvre des derives d'(iso)verbascoside, des (hydrogeno)carbonates et/ou des hydroxydes, et des sels metalliques particuliers
GB201713113D0 (en) * 2017-08-16 2017-09-27 Eccles Nyjon Karl Combination therapy
US11103314B2 (en) 2017-11-24 2021-08-31 Synaptive Medical Inc. Methods and devices for tracking objects by surgical navigation systems
WO2021091358A1 (en) * 2019-11-07 2021-05-14 Lifex Biolabs, Inc. Prostaglandin analogs and uses thereof
JP7141025B1 (ja) * 2021-11-11 2022-09-22 エルデシエロ プライベート リミテッド 化合物、組成物、方法、及び製造方法
CN118436762B (zh) * 2024-04-12 2025-05-27 五邑大学 替考拉宁在制备治疗雄激素性脱发药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
US4352760A (en) 1980-12-29 1982-10-05 The Upjohn Company Organic compounds substituted heptadeca-5,9- and 5,10-dienoic acid
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
DE69823852T2 (de) * 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
ID24845A (id) 1997-09-09 2000-08-24 Procter & Gamble Prostaglandin tetrahidro tersubstitusi c16-c20 aromatik yang berguna sebagai agonis fp
CA2303764C (en) 1997-09-09 2005-02-15 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
WO2003009820A2 (en) * 2001-07-25 2003-02-06 Alcon, Inc. Methods for promotion of hair growth comprising topical application of prostaglandin analogues
US7351404B2 (en) * 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
MXPA05013075A (es) * 2003-06-03 2006-03-17 Novartis Ag Inhibidores de p-38 basados en heterociclo de 5 miembros.
EP1704141B1 (en) * 2004-01-05 2016-02-24 Nicox S.A. Prostaglandin nitrooxyderivatives
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
US7632868B2 (en) * 2007-10-31 2009-12-15 Meta Cosmetics, Llc Prostaglandin analog compositions to treat epithelial-related conditions

Also Published As

Publication number Publication date
US7632868B2 (en) 2009-12-15
WO2009058493A1 (en) 2009-05-07
EP2214482A1 (en) 2010-08-11
US20090111891A1 (en) 2009-04-30
US20090111889A1 (en) 2009-04-30
CN101969772A (zh) 2011-02-09
US7553874B2 (en) 2009-06-30
US7550508B2 (en) 2009-06-23
US7645800B2 (en) 2010-01-12
KR20100099145A (ko) 2010-09-10
US7638557B2 (en) 2009-12-29
US7514474B1 (en) 2009-04-07
US7541382B2 (en) 2009-06-02
AU2008319145A1 (en) 2009-05-07
US20090111761A1 (en) 2009-04-30
US20090111883A1 (en) 2009-04-30
US20090111884A1 (en) 2009-04-30
JP2011502152A (ja) 2011-01-20
US7635720B2 (en) 2009-12-22
US20090111885A1 (en) 2009-04-30
US20090111881A1 (en) 2009-04-30
US20090111882A1 (en) 2009-04-30
RU2010121880A (ru) 2011-12-10
US7649021B2 (en) 2010-01-19
MX2010004834A (es) 2010-10-20
US20090111888A1 (en) 2009-04-30
US20090111887A1 (en) 2009-04-30
US20090111886A1 (en) 2009-04-30
US20090111890A1 (en) 2009-04-30
US7517912B1 (en) 2009-04-14
CA2704337A1 (en) 2009-05-07
EP2214482A4 (en) 2011-08-24
IL205442A0 (en) 2010-12-30
US7553875B2 (en) 2009-06-30
US7632867B2 (en) 2009-12-15
US20090111880A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0815841A2 (pt) Métodos e composições para melhoramento de traços preferidos.
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0807918A2 (pt) composições e método para preservação de tecido
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0809690A2 (pt) Composição de lubrificante, e, método
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
BRPI0909030A2 (pt) composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BRPI0809573A2 (pt) composição, e, método
BRPI0810525A2 (pt) Composições e métodos para a profilaxia e tratamento de dependência química
BRPI0907041A2 (pt) Método para controlar plantas, composto, e, composição herbicida
BRPI0906794A2 (pt) Método para controlar plantas, composto, e, composição herbicida
BRPI1010715A2 (pt) método para controlar insetos e/ou ácaros, e, composição
PT2144998T (pt) Métodos e composições para vírus vivos atenuados
BR112012000171A2 (pt) composição lubrificante, e, método
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0911077A2 (pt) método para tratamento de biomassa
BRPI0814167A2 (pt) Composição, e, método
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI0813922A2 (pt) composições de inibição de influenza e métodos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2480 DE 17-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.